Drugs / Melperone
Melperone
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00125138 | Jul 2005 → Mar 2008 | Parkinson disease, psychotic disorder | Lundbeck LLC | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01323205 Background | May 2011 → Nov 2012 | schizophrenia | Janssen Research & Development, LLC | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Melperone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00125138 ↗ |
| Known as | Bunil | ChEMBL registry synonym — accepted as the source's own label CHEMBL1531134 ↗ |
| Known as | FG 5111 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1531134 ↗ |
| Known as | Melperona | ChEMBL registry synonym — accepted as the source's own label CHEMBL1531134 ↗ |
| Known as | Melperone HCl | “Melperone HCl - 20 mg” NCT00125138 ↗ |
| Known as | Melperone Hydrochloride | “Regular antipsychotic medications (Risperidone, Olanzapine, Clozapine, Amisulpride, Quetiapine, Paliperidone, Aripiprazole, Haloperidol, Levomepromazine, Zuclopenthixol...” NCT01323205 ↗ |
| Known as | Metylperon | ChEMBL registry synonym — accepted as the source's own label CHEMBL1531134 ↗ |
| Modality | Small molecule | — CHEMBL1531134 ↗ |